DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Hattiesburg, MS

12 verified pulmonary disease doctors in Hattiesburg.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Mississippi State Board of Medical Licensure

Dr. Gardner Fletcher, MD

Pulmonary Disease

20 yrs NPPES
NPI 1114982485
200 HOSPITAL DR W, Hattiesburg, MS 39402(601) 296-3000
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $952.15 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$952.15

Total received

49

Transactions

10

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$277.68
AstraZeneca Pharmaceuticals LP$206.45
Grifols USA, LLC$155.41
Boehringer Ingelheim Pharmaceuticals, Inc.$97.09
Mylan Specialty L.P.$78.42
Pfizer Inc.$35.33

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 79th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Gardner Fletcher do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Lewis Neese, MD

Pulmonary Disease

20 yrs NPPES
NPI 1841305950
415 S 28TH AVE, Hattiesburg, MS 39401(601) 268-5650
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,874 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,874

Total received

108

Transactions

22

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$361.75
Mylan Specialty L.P.$290.20
AstraZeneca Pharmaceuticals LP$222.81
Grifols USA, LLC$173.21
Baxter Healthcare$105.67
Axsome Therapeutics, Inc.$83.96

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 85th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Lewis Neese do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Charles Parkman, MD

Pulmonary Disease

20 yrs NPPES
NPI 1558479998
415 S 28TH AVE, Hattiesburg, MS 39401(601) 268-5650
NPPES public registry
CMS Open Payments· $13.73 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$13.73

Total received

1

Transactions

1

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$13.73

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is on the lower end — around the 46th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Charles Parkman do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Steven Stogner, MD

Pulmonary Disease

20 yrs NPPES
NPI 1699884288
415 S 28TH AVE, Hattiesburg, MS 39401(601) 268-5650
NPPES public registry
CMS Open Payments· $41.68 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$41.68

Total received

2

Transactions

1

Paying companies

Top paying companies

Octapharma USA, Inc.$41.68

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 53th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Steven Stogner do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Andrew Rogness, MD

Pulmonary Disease

20 yrs NPPES
NPI 1760588446
415 S 28TH AVE, Hattiesburg, MS 39401(601) 268-5650
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $640.62 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$640.62

Total received

41

Transactions

12

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$201.71
Mylan Specialty L.P.$177.81
Boehringer Ingelheim Pharmaceuticals, Inc.$49.94
AstraZeneca Pharmaceuticals LP$34.80
Grifols USA, LLC$30.70
Inari Medical, Inc.$28.95

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 76th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Andrew Rogness do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Walid Younis, MD

Pulmonary Disease

19 yrs NPPES
NPI 1619018983
415 S 28TH AVE, Hattiesburg, MS 39401(601) 268-5650
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,854 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,854

Total received

108

Transactions

25

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$437.57
AstraZeneca Pharmaceuticals LP$270.61
Actelion Pharmaceuticals US, Inc.$166.52
Baxter Healthcare$151.45
Mylan Specialty L.P.$91.80
Boehringer Ingelheim Pharmaceuticals, Inc.$85.86

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 85th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Walid Younis do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Charles Mccollum, MD

Pulmonary Disease

19 yrs NPPES
NPI 1043418692
415 S 28TH AVE, Hattiesburg, MS 39401(601) 268-5650
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $39.49 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$39.49

Total received

2

Transactions

2

Paying companies

Top paying companies

Merck Sharp & Dohme LLC$22.49
Pfizer Inc.$17.00

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 52th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Charles Mccollum do not imply any wrongdoing. Many are meals, education, or research support.

Dr. L. Aldred, MD

Pulmonary Disease

13 yrs NPPES
NPI 1720428121
415 S 28TH AVE, Hattiesburg, MS 39401(601) 268-5650
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,020 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,020

Total received

110

Transactions

17

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$415.69
Mylan Specialty L.P.$281.76
AstraZeneca Pharmaceuticals LP$241.56
Actelion Pharmaceuticals US, Inc.$166.06
Boehringer Ingelheim Pharmaceuticals, Inc.$159.09
Mallinckrodt Hospital Products Inc.$141.22

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 86th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to L. Aldred do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Robert Walley, MD

Pulmonary Disease

11 yrs NPPES
NPI 1588047567
415 S 28TH AVE, Hattiesburg, MS 39401(601) 268-5650
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $159.45 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$159.45

Total received

4

Transactions

1

Paying companies

Top paying companies

ABIOMED$159.45

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 63th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Robert Walley do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Randolph Ross, MD

Pulmonary Disease

9 yrs NPPES
NPI 1295267680
415 S 28TH AVE, Hattiesburg, MS 39401(601) 268-5650
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $697.58 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$697.58

Total received

38

Transactions

13

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$154.40
Genzyme Corporation$85.39
Boehringer Ingelheim Pharmaceuticals, Inc.$83.10
Mylan Specialty L.P.$69.73
Shionogi Inc$57.12
Actelion Pharmaceuticals US, Inc.$53.06

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 76th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Randolph Ross do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Kevin Kinloch, MD

Pulmonary Disease

9 yrs NPPES
NPI 1952834350
415 S 28TH AVE, Hattiesburg, MS 39401(601) 268-5650
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $904.23 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$904.23

Total received

46

Transactions

17

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$152.74
Mallinckrodt Hospital Products Inc.$93.51
GlaxoSmithKline, LLC.$93.39
Mylan Specialty L.P.$85.00
Ethicon Inc.$69.42
Bayer HealthCare Pharmaceuticals Inc.$59.01

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 79th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Kevin Kinloch do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Anna Gladfelter, MD

Pulmonary Disease

7 yrs NPPES
NPI 1750843330
415 S 28TH AVE, Hattiesburg, MS 39401(601) 268-5650
NPPES public registry
CMS Open Payments· $723.12 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$723.12

Total received

36

Transactions

11

Paying companies

Top paying companies

Mallinckrodt Hospital Products Inc.$167.64
Pfizer Inc.$136.51
AbbVie Inc.$83.78
Boehringer Ingelheim Pharmaceuticals, Inc.$74.14
Inari Medical, Inc.$51.26
Regeneron Healthcare Solutions, Inc.$44.41

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 76th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Anna Gladfelter do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Hattiesburg, MS — Verified | DoctorsProof | DoctorsProof